Seyed Reza Mirhafez
Research Subjects
Seyed Reza Mirhafez has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
- Majid Ghayour-Mobarhan
International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran
18 shared publications Gordon A. Ferns
Division of Medical Education, Brighton & Sussex Medical School, Falmer, Brighton, UK
15 shared publicationsAmir Avan
Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
10 shared publications- Alireza Pasdar
Department of Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran
9 shared publications - Habibollah Esmaily
Department of Biostatistics, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran
9 shared publications Mahmoud Ebrahimi
Cardiovascular Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
8 shared publications
Latest Publications
- 5 March 2019
- Published by Wiley in Nursing Forum
- Vol. 54 (3) , 369-375
Perceptions and practices related to clinical alarms
Background Clinical alarms represent the top hazard listed in the “Top Ten Health Technology Hazards” report. Frequent false alarms can disrupt patient care and reduce trust in alarms. Aim The aim of the present study was to investigate the perceptions and practices of critical and noncritical care nurses regarding clinical alarms. Methodology This was a descriptive analytical study conducted from October 2016 to February 2017 at three hospitals on 197 nurses at Neyshabur University of Medical Sciences in Neyshabur, Northeastern Iran. Participants were selected through stratified random sampling. The perceptions were measured through the 2011 Health care Technology Foundation Clinical Alarms Survey. Results More than half of the nurses believed that frequent false alarms reduced trust in alarms, leading nurses to inappropriately disable alarms. The nurses ranked frequent false alarms as the most important issue in response to alarms. More than 60% of the nurses indicated that they needed more training on the use of bedside and central monitors. Conclusion The result of this study suggested that frequent false alarms, as the most important issue related to alarms, should be taken into account by hospital administrators and researchers to decrease alarm fatigue and improve alarm system safety. More specialized clinical policies and procedures for alarm management should also be considered.
- 5 March 2019
- Published by Wiley in Nursing Forum
- Vol. 54 (3) , 369-375
Perceptions and practices related to clinical alarms
Background Clinical alarms represent the top hazard listed in the “Top Ten Health Technology Hazards” report. Frequent false alarms can disrupt patient care and reduce trust in alarms. Aim The aim of the present study was to investigate the perceptions and practices of critical and noncritical care nurses regarding clinical alarms. Methodology This was a descriptive analytical study conducted from October 2016 to February 2017 at three hospitals on 197 nurses at Neyshabur University of Medical Sciences in Neyshabur, Northeastern Iran. Participants were selected through stratified random sampling. The perceptions were measured through the 2011 Health care Technology Foundation Clinical Alarms Survey. Results More than half of the nurses believed that frequent false alarms reduced trust in alarms, leading nurses to inappropriately disable alarms. The nurses ranked frequent false alarms as the most important issue in response to alarms. More than 60% of the nurses indicated that they needed more training on the use of bedside and central monitors. Conclusion The result of this study suggested that frequent false alarms, as the most important issue related to alarms, should be taken into account by hospital administrators and researchers to decrease alarm fatigue and improve alarm system safety. More specialized clinical policies and procedures for alarm management should also be considered.
- 1 June 2017
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 353 (6) , 552-558
Alterations in Lipid Profile, Zinc and Copper Levels and Superoxide Dismutase Activities in Normal Pregnancy and Preeclampsia
- 1 June 2017
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 353 (6) , 552-558
Alterations in Lipid Profile, Zinc and Copper Levels and Superoxide Dismutase Activities in Normal Pregnancy and Preeclampsia
- 22 May 2017
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 435 (1-2) , 37-45
Serum concentrations of MCP-1 and IL-6 in combination predict the presence of coronary artery disease and mortality in subjects undergoing coronary angiography
Cytokines play a key role in the pathogenesis of coronary artery disease (CAD). The aim of current study was to investigate the relationship between the serum concentrations of 12 cytokines with mortality and extent of CAD in individuals undergoing angiography and healthy controls. 342 CAD patients were recruited and divided into 2 groups: those with ≥50% occlusion in at least one coronary artery [Angiography (+)] or ® was used for measuring 12 cytokines (IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α, MCP-1, IFN-γ, EGF, VEGF) using sandwich chemiluminescent assays. Univariate analysis, multivariate regression models, ROC, and Kaplan–Meier survival curves were used for exploring the candidate markers in CAD patients. Serum level of IFN-γ, IL-4, MCP-1, EGF, IL-6, and IL-8 were markedly higher in angiogram-positive patients, while VEGF concentrations were significantly (P < 0.05) lower, compared to control group. ROC analysis for MCP-1 showed that a cut-off of 61.95 pg/mL had 91% sensitivity and 91% specificity for predicting CAD patients. Moreover, >2.16 pg/mL IL-6 had a > 94% sensitivity and 70% specificity in predicting 2 years mortality in the subjects with a serum MCP-1 > 61.95 pg/ mL, and patients having IL-6/MCP-1 combination had a shorter survival.Our findings demonstrate that CAD patients with serum MCP-1 and IL-6 levels of >61.95 and >2.16 pg/mL had a higher mortality with 94.1% sensitivity and 70.5% specificity for predicting mortality in CAD patients.
- 22 May 2017
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 435 (1-2) , 37-45
Serum concentrations of MCP-1 and IL-6 in combination predict the presence of coronary artery disease and mortality in subjects undergoing coronary angiography
Cytokines play a key role in the pathogenesis of coronary artery disease (CAD). The aim of current study was to investigate the relationship between the serum concentrations of 12 cytokines with mortality and extent of CAD in individuals undergoing angiography and healthy controls. 342 CAD patients were recruited and divided into 2 groups: those with ≥50% occlusion in at least one coronary artery [Angiography (+)] or ® was used for measuring 12 cytokines (IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α, MCP-1, IFN-γ, EGF, VEGF) using sandwich chemiluminescent assays. Univariate analysis, multivariate regression models, ROC, and Kaplan–Meier survival curves were used for exploring the candidate markers in CAD patients. Serum level of IFN-γ, IL-4, MCP-1, EGF, IL-6, and IL-8 were markedly higher in angiogram-positive patients, while VEGF concentrations were significantly (P < 0.05) lower, compared to control group. ROC analysis for MCP-1 showed that a cut-off of 61.95 pg/mL had 91% sensitivity and 91% specificity for predicting CAD patients. Moreover, >2.16 pg/mL IL-6 had a > 94% sensitivity and 70% specificity in predicting 2 years mortality in the subjects with a serum MCP-1 > 61.95 pg/ mL, and patients having IL-6/MCP-1 combination had a shorter survival.Our findings demonstrate that CAD patients with serum MCP-1 and IL-6 levels of >61.95 and >2.16 pg/mL had a higher mortality with 94.1% sensitivity and 70.5% specificity for predicting mortality in CAD patients.
- 23 February 2017
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 32 (1)
Association oftumor necrosis factor‐α‐308 G/Agene polymorphism with coronary artery diseases: An evidence‐based study
Background: Coronary artery disease (CAD) is the leading cause of death worldwide and remains a major health problem, providing the rationale for identification of molecular markers for detection of individuals at high risk of developingCAD. Tumor necrosis factor‐α (TNF‐α) plays a crucial role in the pathogenesis ofCAD. We have therefore explored the association ofTNF‐α308 (G/A)gene polymorphism in 903 individuals with/withoutCAD.Methods: TNF‐α308gene polymorphism was analyzed in 903 subjects of whom 222 were healthy controls. Among the 681 patients who were investigated angiographically, 468 had ≧50% stenosis and 213 patients had TNF‐α‐AAorAGgenotypes were significantly lower in patients classified asCADpatients with ≥ or P=.046) using multivariate analysis. Moreover, we found thatTNF‐α‐308‐AAgenotype was associated with blood pressure andCRPlevel inCADpatients, compared to the wild type‐genotype.Conclusion: Our data showed an association ofTNF‐α‐308G/Apolymorphism withCADpatients with ≥50% obstruction, supporting the need for further investigations on the role ofTNF‐α‐308G/Apolymorphism with hypertension.
- 23 February 2017
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 32 (1)
Association oftumor necrosis factor‐α‐308 G/Agene polymorphism with coronary artery diseases: An evidence‐based study
Background: Coronary artery disease (CAD) is the leading cause of death worldwide and remains a major health problem, providing the rationale for identification of molecular markers for detection of individuals at high risk of developingCAD. Tumor necrosis factor‐α (TNF‐α) plays a crucial role in the pathogenesis ofCAD. We have therefore explored the association ofTNF‐α308 (G/A)gene polymorphism in 903 individuals with/withoutCAD.Methods: TNF‐α308gene polymorphism was analyzed in 903 subjects of whom 222 were healthy controls. Among the 681 patients who were investigated angiographically, 468 had ≧50% stenosis and 213 patients had TNF‐α‐AAorAGgenotypes were significantly lower in patients classified asCADpatients with ≥ or P=.046) using multivariate analysis. Moreover, we found thatTNF‐α‐308‐AAgenotype was associated with blood pressure andCRPlevel inCADpatients, compared to the wild type‐genotype.Conclusion: Our data showed an association ofTNF‐α‐308G/Apolymorphism withCADpatients with ≥50% obstruction, supporting the need for further investigations on the role ofTNF‐α‐308G/Apolymorphism with hypertension.
- 2 December 2016
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 31 (5) , e22100
Relationship between serum cytokines receptors and matrix metalloproteinase 9 levels and coronary artery disease
The prevalence of coronary artery disease (CAD) is increasing globally, supporting the need for the identification of novel biomarkers. Therefore in the present study, we have explored the association of SIL2A, SIL6R, STNFRI, STNFRII, and MMP9 in CAD patients. Twenty one patients with angiographically defined CAD with more than 50% occlusion, at least, in one coronary artery and twenty healthy subjects (n=20) without the history of cardiovascular symptoms were enrolled. Demographic and biochemical analysis (e.g. Total Cholesterol (TC), Triglyceride (TG), and HDL-C) were measured in all the subjects. The level of cytokines receptor (SIL2A, SIL6R, SIL6R, STNFRI, STNFRII, and matrix metallopeptidase 9 (MMP9) were evaluated. Our results showed the higher level of MMP9 in patients group compared to the control subjects, while no significant differences were detected for other cytokines. In particular the level of MMP9 was significantly (P=.015) increased from 181.16 ng/mL (95%CI: 112.1-199.2) to 192.0 ng/mL (95%CI: 181.5-265.2). Moreover, the sensitivity and specificity of MMP9 were 95.45% and 45%, respectively, as detected by receiver operating characteristic (ROC) curves. We demonstrate the significant correlation of MMP-9 with CAD with sensitivity of 95.45%, suggesting its role as a biomarker in CAD patients. Further studies in larger population – preferably multicenter setting – are warranted to explore the functional role of this marker in coronary artery disease.
- 2 December 2016
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 31 (5) , e22100
Relationship between serum cytokines receptors and matrix metalloproteinase 9 levels and coronary artery disease
The prevalence of coronary artery disease (CAD) is increasing globally, supporting the need for the identification of novel biomarkers. Therefore in the present study, we have explored the association of SIL2A, SIL6R, STNFRI, STNFRII, and MMP9 in CAD patients. Twenty one patients with angiographically defined CAD with more than 50% occlusion, at least, in one coronary artery and twenty healthy subjects (n=20) without the history of cardiovascular symptoms were enrolled. Demographic and biochemical analysis (e.g. Total Cholesterol (TC), Triglyceride (TG), and HDL-C) were measured in all the subjects. The level of cytokines receptor (SIL2A, SIL6R, SIL6R, STNFRI, STNFRII, and matrix metallopeptidase 9 (MMP9) were evaluated. Our results showed the higher level of MMP9 in patients group compared to the control subjects, while no significant differences were detected for other cytokines. In particular the level of MMP9 was significantly (P=.015) increased from 181.16 ng/mL (95%CI: 112.1-199.2) to 192.0 ng/mL (95%CI: 181.5-265.2). Moreover, the sensitivity and specificity of MMP9 were 95.45% and 45%, respectively, as detected by receiver operating characteristic (ROC) curves. We demonstrate the significant correlation of MMP-9 with CAD with sensitivity of 95.45%, suggesting its role as a biomarker in CAD patients. Further studies in larger population – preferably multicenter setting – are warranted to explore the functional role of this marker in coronary artery disease.
- 28 September 2016
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 53 (6) , 663-668
Cytokine profiles in overweight and obese subjects and normal weight individuals matched for age and gender
Background: Obesity is associated with a state of systemic inflammation, mediated by adipose tissue-derived cytokines that may also have metabolic effects, including an effect on insulin resistance. The aim of this study was to compare the serum profile of pro- and anti-inflammatory cytokines in obese and non-obese subjects. Methods: A total of 242 subjects who were either overweight or obese (body mass index [BMI] ≥ 25 kg/m 2 ) and non-obese subjects (body mass index 2 ), were recruited in Mashhad in northeastern Iran. The concentrations of serum interleukin-1α, -1β, -2, -4, -6, -8 and -10 (IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8 and IL-10), were measured in all subjects, together with serum vascular endothelial growth factor, interferon-γ, epidermal growth factor, monocyte chemoattractant protein-1 and tumour necrosis factor-α. Results: The groups differed significantly with respect to measures of adiposity and fasted lipid profile. Serum pro-inflammatory cytokines interferon-γ and interleukin-1α, and anti-inflammatory cytokines, interleukin-10, and epidermal growth factor were significantly different between obese and non-obese individuals, as was serum high-sensitivity C-reactive protein. Multivariate regression showed that waist circumference was significantly and independently related to serum monocyte chemoattractant protein-1concentrations ( P = 0.001). Conclusion: Despite significant differences in several cytokines between the groups, only monocyte chemoattractant protein-1appeared to be independently related to a measure of adiposity in this population sample from Iran.
- 28 September 2016
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 53 (6) , 663-668
Cytokine profiles in overweight and obese subjects and normal weight individuals matched for age and gender
Background: Obesity is associated with a state of systemic inflammation, mediated by adipose tissue-derived cytokines that may also have metabolic effects, including an effect on insulin resistance. The aim of this study was to compare the serum profile of pro- and anti-inflammatory cytokines in obese and non-obese subjects. Methods: A total of 242 subjects who were either overweight or obese (body mass index [BMI] ≥ 25 kg/m 2 ) and non-obese subjects (body mass index 2 ), were recruited in Mashhad in northeastern Iran. The concentrations of serum interleukin-1α, -1β, -2, -4, -6, -8 and -10 (IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8 and IL-10), were measured in all subjects, together with serum vascular endothelial growth factor, interferon-γ, epidermal growth factor, monocyte chemoattractant protein-1 and tumour necrosis factor-α. Results: The groups differed significantly with respect to measures of adiposity and fasted lipid profile. Serum pro-inflammatory cytokines interferon-γ and interleukin-1α, and anti-inflammatory cytokines, interleukin-10, and epidermal growth factor were significantly different between obese and non-obese individuals, as was serum high-sensitivity C-reactive protein. Multivariate regression showed that waist circumference was significantly and independently related to serum monocyte chemoattractant protein-1concentrations ( P = 0.001). Conclusion: Despite significant differences in several cytokines between the groups, only monocyte chemoattractant protein-1appeared to be independently related to a measure of adiposity in this population sample from Iran.
- 1 September 2016
- Published by Elsevier in Advances in Medical Sciences
- Vol. 61 (2) , 219-223
Association between serum 25-hydroxyvitamin D concentrations and prevalence of metabolic syndrome
- 1 September 2016
- Published by Elsevier in Advances in Medical Sciences
- Vol. 61 (2) , 219-223
Association between serum 25-hydroxyvitamin D concentrations and prevalence of metabolic syndrome
- 27 July 2016
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 70 (11) , 1298-1304
Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects
European Journal of Clinical Nutrition is a high quality, peer-reviewed journal that covers all aspects of human nutrition.
- 27 July 2016
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 70 (11) , 1298-1304
Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects
European Journal of Clinical Nutrition is a high quality, peer-reviewed journal that covers all aspects of human nutrition.
- 1 July 2016
- Published by Elsevier in Clinical Biochemistry
- Vol. 49 (10-11) , 750-755
Association between serum cytokine concentrations and the presence of hypertriglyceridemia
- 1 July 2016
- Published by Elsevier in Clinical Biochemistry
- Vol. 49 (10-11) , 750-755
Association between serum cytokine concentrations and the presence of hypertriglyceridemia